Hulshoff, Melanie S.
Schellinger, Isabel N.
Xu, Xingbo
Fledderus, Jolien
Rath, Sandip K.
Wong, Fang Cheng
Maamari, Sabine
Haunschild, Josephina
Krenning, Guido
Raaz, Uwe
Zeisberg, Elisabeth M.
Funding for this research was provided by:
University of Leipzig Medical (934300-022)
Deutsche Forschungsgemeinschaft (Sche 2125/2-1)
Deutsches Zentrum für Herz-Kreislaufforschung (81X3300104)
Georg-August-Universität Göttingen
Article History
Received: 23 November 2022
Accepted: 9 December 2022
First Online: 25 January 2023
Declarations
:
: All animal studies were reviewed and approved by the responsible local animal ethics review boards and procedures were conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. Approval for studies on human tissue samples was obtained under informed consent and conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: I.N.S. and U.R. are cofounders of Angiolutions GmbH. Angiolutions GmbH is an academic spin-off company developing vascular devices for aneurysm diseases. There is no conflict of interest with the contents of this work.